(Q42616224)

English

Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial.

scientific article published on 9 March 2009

In more languages
default values for all languages
No label defined

No description defined

Statements

Intravenous recombinant human relaxin in compensated heart failure: a safety, tolerability, and pharmacodynamic trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit